PTHS
AMEX · Biotechnology

Pelthos Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.99
-0.40 (-4.26%)
As of Nov 14, 2:31 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +203.4% upside
Low Target $18.57
Average Target $27.28
High Target $35.01
Current Price $8.99
Current
$8.99
Target
$27.28
$18.57 $27.28 avg $35.01
Scenario Analysis
Bear Case
$18.57
106.6%
Low target
Base Case
$27.28
+203.4%
Avg target
Bull Case
$35.01
+289.4%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$37.40
-76.0% from high
52-Week Low
$7.79
+15.5% from low
Target vs 52W High
$27.28
-27.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -33.8%